Saturday, July 25, 2026

pharma · No medical condition. · Generalized Myasthenia Gravis

Anaxis Pharma

Anaxis Pharma trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Melbourne, AU HQ
2017 Founded
7 Employees
TGA registrant Type
Company details
Status
Public
HQ
Melbourne, AU
Founded
2017
Employees
7
Programs
10
Drugs
582
Patents
0
Intelligence · Clinical Trials

Anaxis Pharma clinical trials

Registry index of 10 ClinicalTrials.gov studies linked to Anaxis Pharma programs — each row shows trial ID, program name, phase, status, and indication.

Anaxis Pharma trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Anaxis Pharma.

  1. CRN00808-08 — Phase 3

    Clinical update
  2. CRN00808-09 — Phase 3

    Clinical update
  3. CAN-201 NDG — Phase 2

    Clinical update
  4. EP-005 — Phase 2

    Clinical update
  5. Paltusotine tablets, Paltusotine tablets — Phase 2

    Clinical update
  6. SNOXA12C401 — Phase 2

    Clinical update
  7. DBP-053-01 — Phase 1

    Clinical update
  8. LY03010/CT-EUR-102 — Phase 1

    Clinical update

Trial registry

10 studies